Skip to content
VuFind
    • English
    • Deutsch
    • Español
    • Français
    • Italiano
    • 日本語
    • Nederlands
    • Português
    • Português (Brasil)
    • 中文(简体)
    • 中文(繁體)
    • Türkçe
    • עברית
    • Gaeilge
    • Cymraeg
    • Ελληνικά
    • Català
    • Euskara
    • Русский
    • Čeština
    • Suomi
    • Svenska
    • polski
    • Dansk
    • slovenščina
    • اللغة العربية
    • বাংলা
    • Galego
    • Tiếng Việt
    • Hrvatski
    • हिंदी
    • Հայերէն
    • Українська
    • Sámegiella
    • Монгол
Advanced
  • Bosentan therapy for chronic t...
  • Cite this
  • Text this
  • Email this
  • Print
  • Export Record
    • Export to RefWorks
    • Export to EndNoteWeb
    • Export to EndNote
  • Permanent link
Bosentan therapy for chronic thromboembolic pulmonary hypertension

Bosentan therapy for chronic thromboembolic pulmonary hypertension

Bibliographic Details
Main Authors: L Huber, U Treder
Format: Article
Language:English
Published: SMW supporting association (Trägerverein Swiss Medical Weekly SMW) 2007-10-01
Series:Swiss Medical Weekly
Subjects:
Bosentan
Endothelin receptor antagonists
chronic thromboembolic pulmonary hypertension
pulmonary arterial hypertension
Online Access:https://www.smw.ch/index.php/smw/article/view/785
  • Holdings
  • Description
  • Similar Items
  • Staff View

Internet

https://www.smw.ch/index.php/smw/article/view/785

Similar Items

  • Lower doses of bosentan in combination with sildenafil might be beneficial in pulmonary arterial hypertension
    by: Ahmad Amin, et al.
    Published: (2015-01-01)
  • Current status of bosentan for treatment of pulmonary hypertension
    by: Raja Shahzad, et al.
    Published: (2008-01-01)
  • Bosentan use in pulmonary arterial hypertension: Russian and foreign experience
    by: Z S Valieva, et al.
    Published: (2017-08-01)
  • Endothelin receptor antagonist bosentan role in modern strategy for patients with pulmonary arterial hypertension treatment
    by: O A Arkhipova, et al.
    Published: (2018-06-01)
  • Endothelin receptor antagonist bosentan role in modern strategy for patients with pulmonary arterial hypertension treatment
    by: Arkhipova O.A., et al.
    Published: (2018-05-01)

Search Options

  • Search History
  • Advanced Search

Find More

  • Browse the Catalog
  • Browse Alphabetically
  • Explore Channels
  • Course Reserves
  • New Items

Need Help?

  • Search Tips
  • Ask a Librarian
  • FAQs